Atlas Trials

Targeting a Genetic Mutation in Glycine Metabolism With D-cycloserine

Clinical trial NCT02304432 · COMPLETED

Trial details

NCT number
NCT02304432
Sponsor
Mclean Hospital
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
SchizophreniaBipolar Disorder
Start date
2015-09-27
Primary completion
2016-09-30
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.